D-dimer assays: The current status and new assay technologies

Thrombosis Research

Volumn 118, Issue 5, 2006, Pages 569-571

  Dempfle, Carl Erik ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; D DIMER; FIBRIN;

BIOASSAY; BIOLOGICAL MONITORING; BIOTECHNOLOGICAL PROCEDURES; BLOOD CLOTTING; BLOOD SAMPLING; CLINICAL DECISION MAKING; CLINICAL INDICATOR; CLINICAL PROTOCOL; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DIAGNOSTIC VALUE; DISSEMINATED INTRAVASCULAR CLOTTING; EDITORIAL; FIBRIN FORMATION; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LUNG EMBOLISM; MOLECULAR WEIGHT; PLASMA; PRIORITY JOURNAL;

ANTIBODIES; BIOTECHNOLOGY; BLOOD COAGULATION TESTS; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; IMMUNOASSAY;

EID: 33748766626     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.08.006     Document Type: Editorial

References (23)

1. Gaffney P.J. Distinction between fibrinogen and fibrin degradation products in plasma. Clin Chim Acta 65 (1975) 109-115
2. Gaffney P.J., Lane D.A., Kakkar V.V., and Brasher M. Characterisation of a soluble D dimer-E complex in crosslinked fibrin digests. Thromb Res 7 (1975) 89-99
3. Gaffney P.J., and Joe F. The lysis of crosslinked human fibrin by plasmin yields initially a single molecular complex, D dimer-E. Thromb Res 15 (1979) 673-687
4. Rylatt D.B., Blake A.S., Cottis L.E., Massingham D.A., Fletcher W.A., Masci P.P., et al. An immunoassay for human D dimer using monoclonal antibodies. Thromb Res 31 (1983) 767-778
5. Gaffney P.J., Edgell T., Creighton-Kempsford L.J., Wheeler S., and Tarelli E. Fibrin degradation product (FnDP) assays: analysis of standardization issues and target antigens in plasma. Br J Haematol 90 (1995) 187-194
6. Pfitzner S.A., Dempfle C.E., Matsuda M., and Heene D.L. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A. Thromb Haemost 78 (1997) 1069-1078
7. Michiels J.J., Kasbergen H., Oudega R., Van Der Graaf F., De Maeseneer M., Van Der Planken M., et al. Exclusion and diagnosis of deep vein thrombosis in outpatients by sequential noninvasive tools. Int Angiol 21 (2002) 9-19
8. Michiels J.J., Freyburger G., van der Graaf F., Janssen M., Oortwijn W., and van Beek E.J. Strategies for the safe and effective exclusion and diagnosis of deep vein thrombosis by the sequential use of clinical score, D-dimer testing, and compression ultrasonography. Semin Thromb Hemost 26 (2000) 657-667
9. Perrier A., and Palareti G. D-dimer testing and venous thromboembolism: four view points. J Thromb Haemost 3 (2005) 382-384
10. Perrier A., Roy P.M., Aujesky D., Chagnon I., Howarth N., Gourdier A.L., et al. Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am J Med 116 (2004) 291-299
11. Heim S.W., Schectman J.M., Siadaty M.S., and Philbrick J.T. D-dimer testing for deep venous thrombosis: a metaanalysis. Clin Chem 50 (2004) 1136-1147
12. Marder V.J. What does the "Dimertest" test?. Circulation 82 (1990) 1514-1515
13. Gaffney P.J. Fibrin degradation products. A review of structures found in vitro and in vivo. Ann N Y Acad Sci 936 (2001) 594-610
14. Nieuwenhuizen W. A reference material for harmonisation of D-dimer assays. Fibrinogen Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thromb Haemost 77 (1997) 1031-1033
15. Dempfle C.E., Zips S., Ergul H., and Heene D.L. The Fibrin Assay Comparison Trial (FACT): correlation of soluble fibrin assays with D-dimer. Thromb Haemost 86 (2001) 1204-1209
16. Dempfle C.E., Zips S., Ergul H., and Heene D.L. The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT study group. Thromb Haemost 85 (2001) 671-678
17. Marder V.J., Budzynski A.Z., and Barlow G.H. Comparison of the physicochemical properties of fragment D derivatives of fibrinogen and fragment D-D of cross-linked fibrin. Biochim Biophys Acta 427 (1976) 1-14
18. Francis C.W., Marder V.J., and Barlow G.H. Plasmic degradation of crosslinked fibrin. Characterization of new macromolecular soluble complexes and a model of their structure. J Clin Invest 66 (1980) 1033-1043
19. Adema E., and Gebert U. Pooled patient samples as reference material for D-dimer. Thromb Res 80 (1995) 85-88
20. Stein P.D., Hull R.D., Patel K.C., Olson R.E., Ghali W.A., Brant R., et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med 140 (2004) 589-602
21. Taylor Jr. F.B., Toh C.H., Hoots W.K., Wada H., and Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86 (2001) 1327-1330
22. Gando S., Wada H., Asakura H., Iba T., Eguchi Y., Okamoto K., et al. Evaluation of new Japanese diagnostic criteria for disseminated intravascular coagulation in critically ill patients. Clin Appl Thromb Hemost 11 (2005) 71-76
23. Bakhtiari K., Meijers J.C., de Jong E., and Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 32 (2004) 2416-2421